CSII News and Press, Cardiovascular Systems Inc. From 08/30/21

Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional ...

The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this event. For further details see: Cardiovascular Systems (CSII) Presents At 6 th Annual Needham Virtual Med Tech & Diagnostics 1X1 Conference - Slideshow

The FDA has approved an expanded label for Eli Lilly's (NYSE:LLY) rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2 diabetes, to include administration via continuous subcutaneous in...

The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this event. For further details see: Cardiovascular Systems (CSII) Presents At 41st Annual Canaccord Genuity Growth Virtual Conference - Slideshow

Cardiovascular Systems, Inc. (CSII) Q4 2021 Earnings Conference Call August 4, 2021, 4:30 PM ET Company Participants Jack Nielsen – Vice President-Investor Relations & Corporate Communications Scott Ward – Chairman, President and Chief Executive Officer Jeff Points – ...

The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Cardiovascular Systems, Inc. 2021 Q2 - Results - Earnings Call Presentation

Image source: The Motley Fool. Cardiovascular Systems, inc (NASDAQ: CSII) Q4 2021 Earnings Call Aug 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cardiovascular Systems, inc (CSII) Q4 2021 Earnings Call Transcr...

Conference Call Scheduled for Today, August 4, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $71.0 million increased 66.8% compared to fourth quarter last year and increased 12.2% sequentially compared to third quarter this year Fiscal 2021 revenues increased 9.5% to ...

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to attend three investor...

Mario13/E+ via Getty Images FibroGen courts downgrades after FDA setback for Roxadustat  FibroGen (FGEN) has lost ~35.7% in the pre-market in reaction to its failure to win the endorsement from FDA’s expert panel for Roxadustat in anemia due to chronic kidney diseas...